Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Hi Tech Pharmacal Co (NASDAQ: HITK ) is 15.77%. Hi Tech Pharmacal's ROE for the same period is 15.20%. The trailing-twelve-month profit margin at Akorn (NASDAQ: AKRX )